C22H27N7O4S
Neat
485.56
1187595-90-9; (4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2, 3-d]pyrimidin-7-yl)methyl pivalate; C9687ZH9QL; (4-(1-(3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo(2, 3-d)pyrimidin-7-yl)methyl pivalate; [4-[1-[3-(Cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[2, 3-d]pyrimidin-7-yl]methyl pivalate; RefChem:1050365; 2, 2-Dimethyl-propionic acid 4-[1-(3-cyanomethyl-1-ethanesulfonyl-azetidin-3-yl)-1H-pyrazol-4-yl]-pyrrolo[2, 3-d]pyrimidin-7-ylmethyl ester; [4-[1-[3-(cyanomethyl)-1-ethylsulfonylazetidin-3-yl]pyrazol-4-yl]pyrrolo[2, 3-d]pyrimidin-7-yl]methyl 2, 2-dimethylpropanoate; Baricitinib Impurity 44; Baricitinib methyl pivalate; SCHEMBL870570; WENIISNHSRPUOW-UHFFFAOYSA-N; DB-200245; CS-0456913; Propanoic acid, 2, 2-dimethyl-, [4-[1-[3-(cyanomethyl)-1-(ethylsulfonyl)-3-azetidinyl]-1H-pyrazol-4-yl]-7H-pyrrolo[2 and 3-d]pyrimidin-7-yl]methyl ester
[4-[1-[3-(cyanomethyl)-1-ethylsulfonylazetidin-3-yl]pyrazol-4-yl]pyrrolo[2, 3-d]pyrimidin-7-yl]methyl 2 and 2-dimethylpropanoate
InChI=1S/C22H27N7O4S/c1-5-34(31,32)28-12-22(13-28,7-8-23)29-11-16(10-26-29)18-17-6-9-27(19(17)25-14-24-18)15-33-20(30)21(2,3)4/h6,9-11,14H,5,7,12-13,15H2,1-4H3